Tačnost nivoa serumskog prokalcitonina, C-reaktivnog proteina i rastvorljivog CD14 podtipa u dijagnozi sepse kod dece

  • Sanja Knežević Rangelov University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
  • Slobodan M. Janković Univerzitet u Kragujevcu, Fakultet medicinskih nauka
Ključne reči: biološki pokazatelji, c-reaktivni protein, deca, dijagnoza, presepsin protein, humani, senzitivnost i specifičnost, sepsa

Sažetak


Uvod/Cilj. Uprkos rasprostranjenom merenju nivoa prokalcitonina, C-reaktivnog proteina (CRP) i rastvorljivog CD14 podtipa (sCD14-ST) u serumu, njihova tačnost u dijagnozi sepse kod dece još nije jasna. Cilj studije bio je da se utvrdi i uporedi dijagnostička tačnost prokalcitonina, CRP-a i sCD14-ST-a kod dece primljene u bolnicu zbog sumnje na sepsu. Metode. Studija je bila dizajnirana kao retrospektivna studija preseka i sprovedena na deci primljenoj u Pedijatrijsku kliniku Kliničkog centra Kragujevac tokom šestomesečnog perioda pod sumnjom na sepsu. Dijagnostička tačnost je bila testirana konstrukcijom kriva prijemnik-operator (KPO) za svaki od testova i poređenjem površina ispod njih. Rezultati. Prokalcitonin je imao najveću površinu ispod krive [0,75; 95% interval poverenja (CI) 0,63–0,88], zatim slede CRP (0,68; 95% CI 0,54–0,81) i sCD14-ST (0,65; 95% CI 0,52–0,79). Razlike između površina ispod KPO krivih nisu bile značajne (CRP vs. prokalcitoninu z = 1,054, p = 0,291; CRP vs. sCD14-ST-u z = 0,238, p = 0,812; prokalcitonin vs. sCD14-STu z = 1,089, p = 0,286). Zaključak. Naša studija je ukazala na relativno nisku senzitivnost i umerenu specifičnost prokalcitonina, CRP-a i sCD14-ST-a u dijagnozi sepse kod dece, kao i sličnu dijagnostičku tačnost ta tri biomarkera.

Biografija autora

Slobodan M. Janković, Univerzitet u Kragujevcu, Fakultet medicinskih nauka

Redovni profesor Farmakologije i toksikologije i Klinicke farmacije

Reference

Goldstein B, Giroir B, Randolph A. International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dys-function in pediatrics. Pediatr Crit Care Med 2005; 6(1): 2–8.

Wu CC, Lan HM, Han ST, Chaou CH, Yeh CF, Liu SH, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care 2017; 7(1): 91.

Pontrelli G, De Crescenzo F, Buzzetti R, Jenkner A, Balduzzi S, Calò Carducci F, et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic in-flammatory syndrome: a meta-analysis. BMC Infect Dis 2017; 17(1): 302.

Mkony MF, Mizinduko MM, Massawe A, Matee M. Management of neonatal sepsis at Muhimbili National Hospital in Dar es Salaam: diagnostic accuracy of C-reactive protein and new-born scale of sepsis and antimicrobial resistance pattern of eti-ological bacteria. BMC Pediatr 2014; 14: 293.

Poggi C, Bianconi T, Gozzini E, Generoso M, Dani C. Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics 2015; 135(1): 68‒75.

Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int 2014; 2014: 547818.

Julián-Jiménez A, Gutiérrez-Martín P, Lizcano-Lizcano A, López-Guerrero MA, Barroso-Manso Á, Heredero-Gálvez E. Usefulness of procalcitonin and C-reactive protein for predicting bacte-remia in urinary tract infections in the emergency department. Actas Urol Esp 2015; 39(8): 502‒10.

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexi-ble statistical power analysis program for the social, behavior-al, and biomedical sciences. Behav Res Methods 2007; 39(2): 175‒91.

Budczies J, Klauschen F, Sinn BV, Győrffy B, Schmitt WD, Darb-Esfahani S, et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One 2012; 7(12): e51862.

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating charac-teristic curves: a nonparametric approach. Biometrics 1988; 44(3): 837‒45.

López Sastre JB, Pérez Solís D, Roqués Serradilla V, Fernández Colomer B, Coto Cotallo GD, Krauel Vidal X, et al. Grupo de Hospitales Castrillo. Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatr 2006; 6: 16.

Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueck-mann M, et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock dur-ing the first week of intensive care treatment. Crit Care 2014; 18(5): 507.

Objavljeno
2021/04/02
Rubrika
Kratko saopštenje